Intra-Cellular Therapies Inc
ITCI - NASDAQ NMS - GLOBAL MARKET
Industry: Pharmaceuticals
Market Cap: 14.0 B
IPO Date: Jan 31, 2014
Country: US
Currency: USD
Shares Outstanding: 106.5 M
Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook
4/15/2025
Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full year.
Source: Yahoo
Johnson & Johnson Expects Lower Earnings Impact From Intra-Cellular Therapies Acquisition
4/2/2025
Johnson & Johnson (JNJ) expects its pending acquisition of Intra-Cellular Therapies (ITCI) to have a
Source: Yahoo
Beam Therapeutics (BEAM) Down 21.4% Since Last Earnings Report: Can It Rebound?
3/27/2025
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Source: Yahoo